CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 3,500 shares at an average $26.38 ($92,325)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Business Officer acquired 3,500 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 4,500 shares (option exercise)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $26.54 ($331,752)
- 4 Open-market sale President and CEO sold 3,500 shares at an average $27.37 ($95,790)
- 4 Open-market sale Chief Financial Officer sold 18,734 shares at an average $30.00 ($562,035)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Conversion Chief Business Officer acquired 8,900 shares (conversion)
- 4 Conversion Director acquired 139,860 shares (conversion)
- 4 Option exercise Chief Financial Officer acquired 19,300 shares (option exercise)
- 4 Conversion Chief Human Resource Officer acquired 3,821 shares (conversion)
- 4 Conversion 10% owner acquired 7,692,307 shares (conversion)
- 4 Conversion Director acquired 0 shares (conversion)
- 4 Option exercise President and CEO acquired 48,840 shares (option exercise)
Page 10 of 11 · 215 filings